tiprankstipranks
Trending News
More News >
Rapport Therapeutics, Inc. (RAPP)
:RAPP
US Market
Advertisement

Rapport Therapeutics, Inc. (RAPP) Ownership - Who Owns Rapport Therapeutics, Inc.?

Compare
83 Followers

Rapport Therapeutics, Inc. (RAPP) Ownership Overview

7.17%24.17%0.03%5.41%63.22%
0.03% Other Institutional Investors
5.41% ETFs
63.22% Public Companies and
Individual Investors
The ownership structure of Rapport Therapeutics, Inc. (RAPP) stock is a mix of institutional, retail, and individual investors. Approximately 29.60% of the company’s stock is owned by Institutional Investors, 7.17% is owned by Insiders, and 63.22% is owned by Public Companies and Individual Investors.
The ownership structure of Rapport Therapeutics, Inc. (RAPP) stock is a mix of institutional, retail, and individual investors. Approximately 24.20% of the company’s stock is owned by Institutional Investors, 7.17% is owned by Insiders, and 5.41% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 15, 2025
xxxxxxxxxxxxx
$1026824
Sep 15, 2025
xxxxxxxxxxxxx
$499188
Sep 11, 2025
xxxxxxxxxxxxx
$79100
Mar 13, 2025
xxxxxxxxxxxxx
$61200

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$1493335
Jun 30, 2025
xxxxxxxxxxxxx
$2103768
Jun 30, 2025
xxxxxxxxxxxxx
$6254523

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,602,529Institution5.64%71,179,168
2,464,536Institution5.34%67,405,060
1,995,594Insider4.33%54,579,496
1,176,835Institution2.55%32,186,437
999,653Institution2.17%27,340,510
927,548Institution2.01%25,368,438
784,534Institution1.70%21,457,005
550,090Institution1.19%15,044,962
498,963Institution1.08%13,646,638
449,695Institution0.98%12,299,158

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,602,529Institution5.64%71,179,168
2,464,536Institution5.34%67,405,060
1,176,835Institution2.55%32,186,437
927,548Institution2.01%25,368,438
498,963Institution1.08%13,646,638
449,695Institution0.98%12,299,158
381,044Institution0.83%10,421,553
339,646Institution0.74%9,289,318
195,711Institution0.42%5,352,696
118,407Institution0.26%3,238,431

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
762,996Institution1.65%13,451,619
428,712Institution0.93%11,725,273
152,284Institution0.33%4,164,967
104,303Institution0.23%2,852,687
89,659Institution0.19%1,580,688
82,241Institution0.18%1,449,909
49,775Institution0.11%877,533
41,177Institution0.09%1,126,191
38,742Institution0.08%1,018,915
21,825Institution0.05%573,998

FAQ

Who Owns Rapport Therapeutics, Inc. (RAPP)?
According to the latest TipRanks data, approximately 0.03% of the company's stock is held by institutional investors, 7.17% is held by insiders, and 63.22% is held by retail investors.
    What percentage of Rapport Therapeutics, Inc. (RAPP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.03% of Rapport Therapeutics, Inc. (RAPP) stock is held by institutional investors.
      What percentage of Rapport Therapeutics, Inc. (RAPP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 63.22% of Rapport Therapeutics, Inc. (RAPP) stock is held by retail investors.
        Who owns the most shares of Rapport Therapeutics, Inc. (RAPP)?
        SMALLCAP World Fund Inc owns the most shares of Rapport Therapeutics, Inc. (RAPP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis